Immunogenetic mechanisms leading to thyroid autoimmunity: Recent advances in identifying susceptibility genes and regions

Current Genomics

Volumn 12, Issue 8, 2011, Pages 526-541

  Brand, Oliver J ^a   Gough, Stephen C L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Association; Autoimmune thyroid disease; Genes; Graves' disease

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; THYROTROPIN RECEPTOR;

ARTICLE; AUTOIMMUNE THYROIDITIS; COPY NUMBER VARIATION; FOLLOW UP; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOGENICITY; IMMUNOPATHOGENESIS; INTRON; LYMPHOCYTE ACTIVATION; PATHOPHYSIOLOGY; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

EID: 82155203114     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/138920211798120790     Document Type: Article

References (169)

1. Vyse, T.J.; Todd, J.A. Genetic analysis of autoimmune disease. Cell, 1996, 85, 311-318.
2. Jacobson, D.L.; Gange, S.J.; Rose, N.R.; Graham, N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol., 1997, 84, 223-243.
3. Walsh, S.J.; Rau, L.M. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am. J. Public Health, 2000, 90, 1463-1466.
4. Tunbridge, W.M.; Evered, D.C.; Hall, R.; Appleton, D.; Brewis, M.; Clark, F.; Evans, J.G.; Young, E.; Bird, T.; Smith, P.A. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxf), 1977, 7, 481-493.
5. Gittoes, N.J.; Franklyn, J.A. Hyperthyroidism. Current treatment guidelines. Drugs, 1998, 55, 543-553.
6. Pearce, E.N.; Farwell, A.P.; Braverman, L.E. Thyroiditis. N. Engl. J. Med., 2003, 348, 2646-2655.
7. Brix, T.H.; Christensen, K.; Holm, N.V.; Harvald, B.; Hegedus, L. A population-based study of Graves' disease in Danish twins. Clin. Endocrinol. (Oxf), 1998, 48, 397-400.
8. Brix, T.H.; Kyvik, K.O.; Christensen, K.; Hegedus, L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab., 2001, 86, 930-934.
9. Ueda, H.; Howson, J.M.; Esposito, L.; Heward, J.; Snook, H.; Chamberlain, G.; Rainbow, D.B.; Hunter, K.M.; Smith, A.N.; Di Genova, G.; Herr, M.H.; Dahlman, I.; Payne, F.; Smyth, D.; Lowe, C.; Twells, R.C.; Howlett, S.; Healy, B.; Nutland, S.; Rance, H.E.; Everett, V.; Smink, L.J.; Lam, A.C.; Cordell, H.J.; Walker, N.M.; Bordin, C.; Hulme, J.; Motzo, C.; Cucca, F.; Hess, J.F.; Metzker, M.L.; Rogers, J.; Gregory, S.; Allahabadia, A.; Nithiyananthan, R.; Tuomilehto-Wolf, E.; Tuomilehto, J.; Bingley, P.; Gillespie, K.M.; Undlien, D.E.; Ronningen, K.S.; Guja, C.; Ionescu-Tirgoviste, C.; Savage, D.A.; Maxwell, A.P.; Carson, D.J.; Patterson, C.C.; Franklyn, J.A.; Clayton, D.G.; Peterson, L.B.; Wicker, L.S.; Todd, J.A.; Gough, S.C. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 2003, 423, 506-511.
10. Brand, O.J.; Lowe, C.E.; Heward, J.M.; Franklyn, J.A.; Cooper, J.D.; Todd, J.A.; Gough, S.C. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin. Endocrinol. (Oxf), 2007, 66, 508-512.
11. Vella, A.; Cooper, J.D.; Lowe, C.E.; Walker, N.; Nutland, S.; Widmer, B.; Jones, R.; Ring, S.M.; McArdle, W.; Pembrey, M.E.; Strachan, D.P.; Dunger, D.B.; Twells, R.C.; Clayton, D.G.; Todd, J.A. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet., 2005, 76, 773-779.
12. Criswell, L.A.; Pfeiffer, K.A.; Lum, R.F.; Gonzales, B.; Novitzke, J.; Kern, M.; Moser, K.L.; Begovich, A.B.; Carlton, V.E.; Li, W.; Lee, A.T.; Ortmann, W.; Behrens, T.W.; Gregersen, P.K. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet., 2005, 76, 561-571.
13. Buetow, K.H.; Ludwigsen, S.; Scherpbier-Heddema, T.; Quillen, J.; Murray, J.C.; Sheffield, V.C.; Duyk, G.M.; Weber, J.L.; Weissenbach, J.; Gyapay, G.; Dib, C.; Vignal, A.; White, R.; Matsunami, N.; Gerken, S.; Melis, R.; Albertsen, H.; Ward, K.; Plaette, R.; Odelberg, S.; Ward, D.; Bray-Ward, P.; Menninger, J.; Lieman, J.; Desai, T.; Bank, A. Human genetic map. Genome maps V. Wall chart. Science, 1994, 265, 2055-2070.
14. Davies, J.L.; Kawaguchi, Y.; Bennett, S.T.; Copeman, J.B.; Cordell, H.J.; Pritchard, L.E.; Reed, P.W.; Gough, S.C.; Jenkins, S.C.; Palmer, S.M.; Balfour, K.M.; Rowe, B.R.; Farrall, M.; Barnett, A.H.; Bain, S.C.; Todd, J.A. A genome-wide search for human type 1 diabetes susceptibility genes. Nature, 1994, 371, 130-136.
15. Todd, J.A. Genetic analysis of type 1 diabetes using whole genome approaches. Proc. Natl. Acad. Sci. U S A, 1995, 92, 8560-8565.
16. Tomer, Y.; Barbesino, G.; Greenberg, D.A.; Concepcion, E.; Davies, T.F. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J. Clin. Endocrinol. Metab., 1999, 84, 4656-4664.
17. Tomer, Y.; Ban, Y.; Concepcion, E.; Barbesino, G.; Villanueva, R.; Greenberg, D.A.; Davies, T.F. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet., 2003, 73, 736-747.
18. Taylor, J.C.; Gough, S.C.; Hunt, P.J.; Brix, T.H.; Chatterjee, K.; Connell, J.M.; Franklyn, J.A.; Hegedus, L.; Robinson, B.G.; Wiersinga, W.M.; Wass, J.A.; Zabaneh, D.; Mackay, I.; Weetman, A.P. A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J. Clin. Endocrinol. Metab., 2006, 91, 646-653.
19. Sakai, K.; Shirasawa, S.; Ishikawa, N.; Ito, K.; Tamai, H.; Kuma, K.; Akamizu, T.; Tanimura, M.; Furugaki, K.; Yamamoto, K.; Sasazuki, T. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23- q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum. Mol. Genet., 2001, 10, 1379-1386.
20. Jin, Y.; Teng, W.; Ben, S.; Xiong, X.; Zhang, J.; Xu, S.; Shugart, Y.Y.; Jin, L.; Chen, J.; Huang, W. Genome-wide scan of Graves' disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees. J. Clin. Endocrinol. Metab., 2003, 88, 1798-1803.
21. Wainwright, B.J.; Scambler, P.J.; Schmidtke, J.; Watson, E.A.; Law, H.Y.; Farrall, M.; Cooke, H.J.; Eiberg, H.; Williamson, R. Localization of cystic fibrosis locus to human chromosome 7cenq22. Nature, 1985, 318, 384-385.
22. Froguel, P.; Vaxillaire, M.; Sun, F.; Velho, G.; Zouali, H.; Butel, M.O.; Lesage, S.; Vionnet, N.; Clement, K.; Fougerousse, F; et al. Close linkage of glucokinase locus on chromosome 7p to earlyonset non-insulin-dependent diabetes mellitus. Nature, 1992, 356, 162-164.
23. Bell, G.I.; Xiang, K.S.; Newman, M.V.; Wu, S.H.; Wright, L.G.; Fajans, S.S.; Spielman, R.S.; Cox, N.J. Gene for non-insulindependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc. Natl. Acad. Sci. U S A, 1991, 88, 1484-1488.
24. Tomer, Y.; Barbesino, G.; Greenberg, D.A.; Concepcion, E.; Davies, T.F. Linkage analysis of candidate genes in autoimmune thyroid disease. III. Detailed analysis of chromosome 14 localizes Graves' disease-1 (GD-1) close to multinodular goiter-1 (MNG-1). International Consortium for the Genetics of Autoimmune Thyroid Disease. J. Clin. Endocrinol. Metab., 1998, 83, 4321-4327.
25. Cuddihy, R.M.; Dutton, C.M.; Bahn, R.S. A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid, 1995, 5, 89-95.
26. Kotsa, K.D.; Watson, P.F.; Weetman, A.P. No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population. Thyroid, 1997, 7, 31-33.
27. Yanagawa, T.; Hidaka, Y.; Guimaraes, V.; Soliman, M.; DeGroot, L.J. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab., 1995, 80, 41-45.
28. Heward, J.M.; Allahabadia, A.; Daykin, J.; Carr-Smith, J.; Daly, A.; Armitage, M.; Dodson, P.M.; Sheppard, M.C.; Barnett, A.H.; Franklyn, J.A.; Gough, S.C. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J. Clin. Endocrinol. Metab., 1998, 83, 3394-3397.
29. Chen, Q.Y.; Huang, W.; She, J.X.; Baxter, F.; Volpe, R.; Maclaren, N.K. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1* 07 is protective. J. Clin. Endocrinol. Metab., 1999, 84, 3182-3186.
30. Heward, J.M.; Allahabadia, A.; Armitage, M.; Hattersley, A.; Dodson, P.M.; Macleod, K.; Carr-Smith, J.; Daykin, J.; Daly, A.; Sheppard, M.C.; Holder, R.L.; Barnett, A.H.; Franklyn, J.A.; Gough, S.C. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J. Clin. Endocrinol. Metab., 1999, 84, 2398-2401.
31. Braun, J.; Donner, H.; Siegmund, T.; Walfish, P.G.; Usadel, K.H.; Badenhoop, K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens, 1998, 51, 563-566.
32. Vaidya, B.; Oakes, E.J.; Imrie, H.; Dickinson, A.J.; Perros, P.; Kendall-Taylor, P.; Pearce, S.H. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clin Endocrinol (Oxf), 2003, 58, 732-735.
33. Cudworth, A.G.; Woodrow, J.C. HL-A system and diabetes mellitus. Diabetes, 1975, 24, 345-349.
34. Nerup, J.; Platz, P.; Andersen, O.O.; Christy, M.; Lyngsoe, J.; Poulsen, J.E.; Ryder, L.P.; Nielsen, L.S.; Thomsen, M.; Svejgaard, A. HL-A antigens and diabetes mellitus. Lancet, 1974, 2, 864-866.
35. Singal, D.P.; Blajchman, M.A. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes, 1973, 22, 429-432.
36. Cuddihy, R.M.; Bahn, R.S. Lack of an independent association between the human leukocyte antigen allele DQA1*0501 and Graves' disease. J. Clin. Endocrinol. Metab., 1996, 81, 847-849.
37. Shields, D.C.; Ratanachaiyavong, S.; McGregor, A.M.; Collins, A.; Morton, N.E. Combined segregation and linkage analysis of Graves disease with a thyroid autoantibody diathesis. Am. J. Hum. Genet., 1994, 55, 540-554.
38. Yanagawa, T.; Mangklabruks, A.; Chang, Y.B.; Okamoto, Y.; Fisfalen, M.E.; Curran, P.G.; DeGroot, L.J. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab., 1993, 76, 1569-1574.
39. Boehm, B.O.; Kuhnl, P.; Manfras, B.J.; Chen, M.; Lee, J.C.; Holzberger, G.; Seidl, S.; Schifferdecker, E.; Schumm-Draeger, P.M.; Usadel, K.H. HLA-DRB3 gene alleles in Caucasian patients with Graves' disease. Clin. Investig., 1992, 70, 956-960.
40. Roman, S.H.; Greenberg, D.; Rubinstein, P.; Wallenstein, S.; Davies, T.F. Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J. Clin. Endocrinol. Metab., 1992, 74, 496-503.
41. Farid, N.R.; Stone, E.; Johnson, G. Graves' disease and HLA: clinical and epidemiologic associations. Clin. Endocrinol. (Oxf), 1980, 13, 535-544.
42. Simmonds, M.J.; Howson, J.M.; Heward, J.M.; Carr-Smith, J.; Franklyn, J.A.; Todd, J.A.; Gough, S.C. A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Hum. Mol. Genet., 2007, 16, 2149-2153.
43. Simmonds, M.J.; Howson, J.M.; Heward, J.M.; Cordell, H.J.; Foxall, H.; Carr-Smith, J.; Gibson, S.M.; Walker, N.; Tomer, Y.; Franklyn, J.A.; Todd, J.A.; Gough, S.C. Regression mapping of association between the human leukocyte antigen region and Graves disease. Am. J. Hum. Genet., 2005, 76, 157-163.
44. Ban, Y.; Davies, T.F.; Greenberg, D.A.; Concepcion, E.S.; Osman, R.; Oashi, T.; Tomer, Y. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun., 2004, 5, 203-208.
45. Stram, D.O. Tag SNP selection for association studies. Genet. Epidemiol., 2004, 27, 365-374.
46. Burkett, K.M.; Ghadessi, M.; McNeney, B.; Graham, J.; Daley, D. A comparison of five methods for selecting tagging singlenucleotide polymorphisms. BMC Genet., 2005, 6 Suppl 1, S71.
47. Mueller, J.C.; Lohmussaar, E.; Magi, R.; Remm, M.; Bettecken, T.; Lichtner, P.; Biskup, S.; Illig, T.; Pfeufer, A.; Luedemann, J.; Schreiber, S.; Pramstaller, P.; Pichler, I.; Romeo, G.; Gaddi, A.; Testa, A.; Wichmann, H.E.; Metspalu, A.; Meitinger, T. Linkage disequilibrium patterns and tagSNP transferability among European populations. Am. J. Hum. Genet., 2005, 76, 387-398.
48. Johnson, G.C.; Esposito, L.; Barratt, B.J.; Smith, A.N.; Heward, J.; Di Genova, G.; Ueda, H.; Cordell, H.J.; Eaves, I.A.; Dudbridge, F.; Twells, R.C.; Payne, F.; Hughes, W.; Nutland, S.; Stevens, H.; Carr, P.; Tuomilehto-Wolf, E.; Tuomilehto, J.; Gough, S.C.; Clayton, D.G.; Todd, J.A. Haplotype tagging for the identification of common disease genes. Nat. Genet., 2001, 29, 233-237.
49. Myers, S.; Bottolo, L.; Freeman, C.; McVean, G.; Donnelly, P. A fine-scale map of recombination rates and hotspots across the human genome. Science, 2005, 310, 321-324.
50. Ploski, R.; Brand, O.J.; Jurecka-Lubieniecka, B.; Franaszczyk, M.; Kula, D.; Krajewski, P.; Karamat, M.A.; Simmonds, M.J.; Franklyn, J.A.; Gough, S.C.; Jarzab, B.; Bednarczuk, T. Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts. PLoS ONE, 2010, 5, e15512.
51. Song, H.D.; Liang, J.; Shi, J.Y.; Zhao, S.X.; Liu, Z.; Zhao, J.J.; Peng, Y.D.; Gao, G.Q.; Tao, J.; Pan, C.M.; Shao, L.; Cheng, F.; Wang, Y.; Yuan, G.Y.; Xu, C.; Han, B.; Huang, W.; Chu, X.; Chen, Y.; Sheng, Y.; Li, R.Y.; Su, Q.; Gao, L.; Jia, W.P.; Jin, L.; Chen, M.D.; Chen, S.J.; Chen, Z.; Chen, J.L. Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease. Hum. Mol. Genet., 2009, 18, 1156-1170.
52. Chistiakov, D.A.; Voronova, N.V.; Turakulov, R.I.; Savost'anov, K.V. The -112G > A polymorphism of the secretoglobin 3A2 (SCGB3A2) gene encoding uteroglobin-related protein 1 (UGRP1) increases risk for the development of Graves' disease in subsets of patients with elevated levels of immunoglobulin E. J. Appl. Genet., 2011, 52, 201-207.
53. Sale, M.M.; Akamizu, T.; Howard, T.D.; Yokota, T.; Nakao, K.; Mori, T.; Iwasaki, H.; Rich, S.S.; Jennings-Gee, J.E.; Yamada, M.; Bowden, D.W. Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA- 4 in a Japanese population. Proc. Assoc. Am. Physicians, 1997, 109, 453-461.
54. Akamizu, T.; Sale, M.M.; Rich, S.S.; Hiratani, H.; Noh, J.Y.; Kanamoto, N.; Saijo, M.; Miyamoto, Y.; Saito, Y.; Nakao, K.; Bowden, D.W. Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA- 4 in Japanese patients. Thyroid, 2000, 10, 851-858.
55. Brand, O.J.; Gough, S.C. Genetics of thyroid autoimmunity and the role of the TSHR. Mol. Cell Endocrinol., 2010, 322, 135-143.
56. Dechairo, B.M.; Zabaneh, D.; Collins, J.; Brand, O.; Dawson, G.J.; Green, A.P.; Mackay, I.; Franklyn, J.A.; Connell, J.M.; Wass, J.A.; Wiersinga, W.M.; Hegedus, L.; Brix, T.; Robinson, B.G.; Hunt, P.J.; Weetman, A.P.; Carey, A.H.; Gough, S.C. Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur. J. Hum. Genet., 2005, 13, 1223-1230.
57. Hiratani, H.; Bowden, D.W.; Ikegami, S.; Shirasawa, S.; Shimizu, A.; Iwatani, Y.; Akamizu, T. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J. Clin. Endocrinol. Metab., 2005, 90, 2898-2903.
58. Brand, O.J.; Barrett, J.C.; Simmonds, M.J.; Newby, P.R.; McCabe, C.J.; Bruce, C.K.; Kysela, B.; Carr-Smith, J.D.; Brix, T.; Hunt, P.J.; Wiersinga, W.M.; Hegedus, L.; Connell, J.; Wass, J.A.; Franklyn, J.A.; Weetman, A.P.; Heward, J.M.; Gough, S.C. Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Hum. Mol. Genet., 2009, 18, 1704-1713.
59. Ikeda, Y.; Yoshida, W.; Noguchi, T.; Asaba, K.; Nishioka, T.; Takao, T.; Hashimoto, K. Lack of association between IL-12B gene polymorphism and autoimmune thyroid disease in Japanese patients. Endocr. J., 2004, 51, 609-613.
60. Hiromatsu, Y.; Fukutani, T.; Ichimura, M.; Mukai, T.; Kaku, H.; Miyake, I.; Yamada, K. Interleukin-12B gene polymorphism does not confer susceptibility to Graves' ophthalmopathy in Japanese population. Endocr. J., 2006, 53, 753-759.
61. Yang, Y.; Lingling, S.; Ying, J.; Yushu, L.; Zhongyan, S.; Wei, H.; Weiping, T. Association study between the IL4, IL13, IRF1 and UGRP1 genes in chromosomal 5q31 region and Chinese Graves' disease. J. Hum. Genet., 2005, 50, 574-582.
62. Simmonds, M.J.; Heward, J.M.; Franklyn, J.A.; Gough, S.C. IL-13 and chromosome 5q31-q33: problems of identifying association within regions of linkage to Graves' disease. Clin. Endocrinol. (Oxf), 2005, 63, 695-697.
63. Bednarczuk, T.; Placha, G.; Jazdzewski, K.; Kurylowicz, A.; Kloza, M.; Makowska, U.; Hiromatsu, Y.; Nauman, J. Interleukin- 13 gene polymorphisms in patients with Graves' disease. Clin. Endocrinol. (Oxf), 2003, 59, 519-525.
64. Chu, X.; Dong, Y.; Shen, M.; Sun, L.; Dong, C.; Wang, Y.; Wang, B.; Zhang, K.; Hua, Q.; Xu, S.; Huang, W. Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a metaanalysis of available evidence. BMC Med. Genet., 2009, 10, 26.
65. Simmonds, M.J.; Yesmin, K.; Newby, P.R.; Brand, O.J.; Franklyn, J.A.; Gough, S.C. Confirmation of association of chromosome 5q31-33 with United Kingdom Caucasian Graves' disease. Thyroid, 2010, 20, 413-417.
66. Chu, X.; Dong, C.; Lei, R.; Sun, L.; Wang, Z.; Dong, Y.; Shen, M.; Wang, Y.; Wang, B.; Zhang, K.; Yang, L.; Li, Y.; Yuan, W.; Song, H.; Jin, L.; Xiong, M.; Huang, W. Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population. Genes Immun., 2009, 10, 260-266.
67. Cohen, S.; Dadi, H.; Shaoul, E.; Sharfe, N.; Roifman, C.M. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood, 1999, 93, 2013-2024.
68. Bottini, N.; Musumeci, L.; Alonso, A.; Rahmouni, S.; Nika, K.; Rostamkhani, M.; MacMurray, J.; Meloni, G.F.; Lucarelli, P.; Pellecchia, M.; Eisenbarth, G.S.; Comings, D.; Mustelin, T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet., 2004, 36, 337-338.
69. Smyth, D.; Cooper, J.D.; Collins, J.E.; Heward, J.M.; Franklyn, J.A.; Howson, J.M.; Vella, A.; Nutland, S.; Rance, H.E.; Maier, L.; Barratt, B.J.; Guja, C.; Ionescu-Tirgoviste, C.; Savage, D.A.; Dunger, D.B.; Widmer, B.; Strachan, D.P.; Ring, S.M.; Walker, N.; Clayton, D.G.; Twells, R.C.; Gough, S.C.; Todd, J.A. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes, 2004, 53, 3020-3023.
70. Velaga, M.R.; Wilson, V.; Jennings, C.E.; Owen, C.J.; Herington, S.; Donaldson, P.T.; Ball, S.G.; James, R.A.; Quinton, R.; Perros, P.; Pearce, S.H. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J. Clin. Endocrinol. Metab., 2004, 89, 5862-5865.
71. Begovich, A.B.; Carlton, V.E.; Honigberg, L.A.; Schrodi, S.J.; Chokkalingam, A.P.; Alexander, H.C.; Ardlie, K.G.; Huang, Q.; Smith, A.M.; Spoerke, J.M.; Conn, M.T.; Chang, M.; Chang, S.Y.; Saiki, R.K.; Catanese, J.J.; Leong, D.U.; Garcia, V.E.; McAllister, L.B.; Jeffery, D.A.; Lee, A.T.; Batliwalla, F.; Remmers, E.; Criswell, L.A.; Seldin, M.F.; Kastner, D.L.; Amos, C.I.; Sninsky, J.J.; Gregersen, P.K. A missense single-nucleotide Polymorphism In A gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet., 2004, 75, 330-337.
72. Kyogoku, C.; Langefeld, C.D.; Ortmann, W.A.; Lee, A.; Selby, S.; Carlton, V.E.; Chang, M.; Ramos, P.; Baechler, E.C.; Batliwalla, F.M.; Novitzke, J.; Williams, A.H.; Gillett, C.; Rodine, P.; Graham, R.R.; Ardlie, K.G.; Gaffney, P.M.; Moser, K.L.; Petri, M.; Begovich, A.B.; Gregersen, P.K.; Behrens, T.W. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet., 2004, 75, 504-507.
73. Heward, J.M.; Brand, O.J.; Barrett, J.C.; Carr-Smith, J.D.; Franklyn, J.A.; Gough, S.C. Association of PTPN22 haplotypes with Graves' disease. J. Clin. Endocrinol. Metab., 2007, 92, 685-690.
74. Malek, T.R.; Bayer, A.L. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol, 2004, 4, 665-674.
75. Xiong, M.; Zhao, J.; Boerwinkle, E. Generalized T2 test for genome association studies. Am. J. Hum. Genet., 2002, 70, 1257-1268.
76. Chapman, J.M.; Cooper, J.D.; Todd, J.A.; Clayton, D.G. Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum. Hered., 2003, 56, 18-31.
77. Ban, Y.; Tozaki, T.; Taniyama, M.; Nakano, Y.; Hirano, T. Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population. Thyroid, 2010, 20, 893-899.
78. Lowe, C.E.; Cooper, J.D.; Brusko, T.; Walker, N.M.; Smyth, D.J.; Bailey, R.; Bourget, K.; Plagnol, V.; Field, S.; Atkinson, M.; Clayton, D.G.; Wicker, L.S.; Todd, J.A. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat. Genet., 2007, 39, 1074-1082.
79. Hafler, D.A.; Compston, A.; Sawcer, S.; Lander, E.S.; Daly, M.J.; De Jager, P.L.; de Bakker, P.I.; Gabriel, S.B.; Mirel, D.B.; Ivinson, A.J.; Pericak-Vance, M.A.; Gregory, S.G.; Rioux, J.D.; McCauley, J.L.; Haines, J.L.; Barcellos, L.F.; Cree, B.; Oksenberg, J.R.; Hauser, S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med., 2007, 357, 851-862.
80. Matesanz, F.; Caro-Maldonado, A.; Fedetz, M.; Fernandez, O.; Milne, R.L.; Guerrero, M.; Delgado, C.; Alcina, A. IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. J. Neurol., 2007, 254, 682-684.
81. Maier, L.M.; Lowe, C.E.; Cooper, J.; Downes, K.; Anderson, D.E.; Severson, C.; Clark, P.M.; Healy, B.; Walker, N.; Aubin, C.; Oksenberg, J.R.; Hauser, S.L.; Compston, A.; Sawcer, S.; De Jager, P.L.; Wicker, L.S.; Todd, J.A.; Hafler, D.A. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet., 2009, 5, e1000322.
82. Barrett, J.C.; Hansoul, S.; Nicolae, D.L.; Cho, J.H.; Duerr, R.H.; Rioux, J.D.; Brant, S.R.; Silverberg, M.S.; Taylor, K.D.; Barmada, M.M.; Bitton, A.; Dassopoulos, T.; Datta, L.W.; Green, T.; Griffiths, A.M.; Kistner, E.O.; Murtha, M.T.; Regueiro, M.D.; Rotter, J.I.; Schumm, L.P.; Steinhart, A.H.; Targan, S.R.; Xavier, R.J.; Libioulle, C.; Sandor, C.; Lathrop, M.; Belaiche, J.; Dewit, O.; Gut, I.; Heath, S.; Laukens, D.; Mni, M.; Rutgeerts, P.; Van Gossum, A.; Zelenika, D.; Franchimont, D.; Hugot, J.P.; de Vos, M.; Vermeire, S.; Louis, E.; Cardon, L.R.; Anderson, C.A.; Drummond, H.; Nimmo, E.; Ahmad, T.; Prescott, N.J.; Onnie, C.M.; Fisher, S.A.; Marchini, J.; Ghori, J.; Bumpstead, S.; Gwilliam, R.; Tremelling, M.; Deloukas, P.; Mansfield, J.; Jewell, D.; Satsangi, J.; Mathew, C.G.; Parkes, M.; Georges, M.; Daly, M.J. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet., 2008, 40, 955-962.
83. Collins, J.E.; Heward, J.M.; Carr-Smith, J.; Daykin, J.; Franklyn, J.A.; Gough, S.C. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J. Clin. Endocrinol. Metab., 2003, 88, 5039-5042.
84. Collins, J.E.; Heward, J.M.; Howson, J.M.; Foxall, H.; Carr-Smith, J.; Franklyn, J.A.; Gough, S.C. Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom. J. Clin. Endocrinol. Metab., 2004, 89, 6336-6339.
85. Tomer, Y.; Greenberg, D. The thyroglobulin gene as the first thyroid-specific susceptibility gene for autoimmune thyroid disease. Trends Mol. Med., 2004, 10, 306-308.
86. Tomer, Y.; Greenberg, D.A.; Concepcion, E.; Ban, Y.; Davies, T.F. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J. Clin. Endocrinol. Metab., 2002, 87, 404-407.
87. Houston, F.A.; Wilson, V.; Jennings, C.E.; Owen, C.J.; Donaldson, P.; Perros, P.; Pearce, S.H. Role of the CD40 locus in Graves' disease. Thyroid, 2004, 14, 506-509.
88. Jacobson, E.M.; Concepcion, E.; Oashi, T.; Tomer, Y. A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology, 2005, 146, 2684-2691.
89. Tomer, Y.; Concepcion, E.; Greenberg, D.A. A C/T singlenucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid, 2002, 12, 1129-1135.
90. Ban, Y.; Tozaki, T.; Tobe, T.; Jacobson, E.M.; Concepcion, E.S.; Tomer, Y. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J. Autoimmun., 2007, 28, 201-207.
91. Owen, C.J.; Eden, J.A.; Jennings, C.E.; Wilson, V.; Cheetham, T.D.; Pearce, S.H. Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J. Mol. Endocrinol., 2006, 37, 97-104.
92. Collins, J.E.; Heward, J.M.; Nithiyananthan, R.; Nejentsev, S.; Todd, J.A.; Franklyn, J.A.; Gough, S.C. Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clin. Endocrinol. (Oxf), 2004, 60, 618-624.
93. Ramos-Lopez, E.; Kurylowicz, A.; Bednarczuk, T.; Paunkovic, J.; Seidl, C.; Badenhoop, K. Vitamin D receptor polymorphisms are associated with Graves' disease in German and Polish but not in Serbian patients. Thyroid, 2005, 15, 1125-1130.
94. Stefanic, M.; Karner, I.; Glavas-Obrovac, L.; Papic, S.; Vrdoljak, D.; Levak, G.; Krstonosic, B. Association of vitamin D receptor gene polymorphism with susceptibility to Graves' disease in Eastern Croatian population: case-control study. Croat. Med. J., 2005, 46, 639-646.
95. Barrett, J.C.; Cardon, L.R. Evaluating coverage of genome-wide association studies. Nat. Genet., 2006, 38, 659-662.
96. WTCCC; Burton, P.R.; Clayton, D.G.; Cardon, L.R.; Craddock, N.; Deloukas, P.; Duncanson, A.; Kwiatkowski, D.P.; McCarthy, M.I.; Ouwehand, W.H.; Samani, N.J.; Todd, J.A.; Donnelly, P.; Barrett, J.C.; Davison, D.; Easton, D.; Evans, D.M.; Leung, H.T.; Marchini, J.L.; Morris, A.P.; Spencer, C.C.; Tobin, M.D.; Attwood, A.P.; Boorman, J.P.; Cant, B.; Everson, U.; Hussey, J.M.; Jolley, J.D.; Knight, A.S.; Koch, K.; Meech, E.; Nutland, S.; Prowse, C.V.; Stevens, H.E.; Taylor, N.C.; Walters, G.R.; Walker, N.M.; Watkins, N.A.; Winzer, T.; Jones, R.W.; McArdle, W.L.; Ring, S.M.; Strachan, D.P.; Pembrey, M.; Breen, G.; St Clair, D.; Caesar, S.; Gordon-Smith, K.; Jones, L.; Fraser, C.; Green, E.K.; Grozeva, D.; Hamshere, M.L.; Holmans, P.A.; Jones, I.R.; Kirov, G.; Moskivina, V.; Nikolov, I.; O'Donovan, M.C.; Owen, M.J.; Collier, D.A.; Elkin, A.; Farmer, A.; Williamson, R.; McGuffin, P.; Young, A.H.; Ferrier, I.N.; Ball, S.G.; Balmforth, A.J.; Barrett, J.H.; Bishop, T.D.; Iles, M.M.; Maqbool, A.; Yuldasheva, N.; Hall, A.S.; Braund, P.S.; Dixon, R.J.; Mangino, M.; Stevens, S.; Thompson, J.R.; Bredin, F.; Tremelling, M.; Parkes, M.; Drummond, H.; Lees, C.W.; Nimmo, E.R.; Satsangi, J.; Fisher, S.A.; Forbes, A.; Lewis, C.M.; Onnie, C.M.; Prescott, N.J.; Sanderson, J.; Matthew, C.G.; Barbour, J.; Mohiuddin, M.K.; Todhunter, C.E.; Mansfield, J.C.; Ahmad, T.; Cummings, F.R.; Jewell, D.P.; Webster, J.; Brown, M.J.; Lathrop, M.G.; Connell, J.; Dominiczak, A.; Marcano, C.A.; Burke, B.; Dobson, R.; Gungadoo, J.; Lee, K.L.; Munroe, P.B.; Newhouse, S.J.; Onipinla, A.; Wallace, C.; Xue, M.; Caulfield, M.; Farrall, M.; Barton, A.; Bruce, I.N.; Donovan, H.; Eyre, S.; Gilbert, P.D.; Hilder, S.L.; Hinks, A.M.; John, S.L.; Potter, C.; Silman, A.J.; Symmons, D.P.; Thomson, W.; Worthington, J.; Dunger, D.B.; Widmer, B.; Frayling, T.M.; Freathy, R.M.; Lango, H.; Perry, J.R.; Shields, B.M.; Weedon, M.N.; Hattersley, A.T.; Hitman, G.A.; Walker, M.; Elliott, K.S.; Groves, C.J.; Lindgren, C.M.; Rayner, N.W.; Timpson, N.J.; Zeggini, E.; Newport, M.; Sirugo, G.; Lyons, E.; Vannberg, F.; Hill, A.V.; Bradbury, L.A.; Farrar, C.; Pointon, J.J.; Wordsworth, P.; Brown, M.A.; Franklyn, J.A.; Heward, J.M.; Simmonds, M.J.; Gough, S.C.; Seal, S.; Stratton, M.R.; Rahman, N.; Ban, M.; Goris, A.; Sawcer, S.J.; Compston, A.; Conway, D.; Jallow, M.; Newport, M.; Sirugo, G.; Rockett, K.A.; Bumpstead, S.J.; Chaney, A.; Downes, K.; Ghori, M.J.; Gwilliam, R.; Hunt, S.E.; Inouye, M.; Keniry, A.; King, E.; McGinnis, R.; Potter, S.; Ravindrarajah, R.; Whittaker, P.; Widden, C.; Withers, D.; Cardin, N.J.; Davison, D.; Ferreira, T.; Pereira- Gale, J.; Hallgrimsdo'ttir, I.B.; Howie, B.N.; Su, Z.; Teo, Y.Y.; Vukcevic, D.; Bentley, D.; Brown, M.A.; Compston, A.; Farrall, M.; Hall, A.S.; Hattersley, A.T.; Hill, A.V.; Parkes, M.; Pembrey, M.; Stratton, M.R.; Mitchell, S.L.; Newby, P.R.; Brand, O.J.; Carr- Smith, J.; Pearce, S.H.; McGinnis, R.; Keniry, A.; Deloukas, P.; Reveille, J.D.; Zhou, X.; Sims, A.M.; Dowling, A.; Taylor, J.; Doan, T.; Davis, J.C.; Savage, L.; Ward, M.M.; Learch, T.L.; Weisman, M.H.; Brown, M. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet., 2007, 39, 1329-1337.
97. Kochi, Y.; Yamada, R.; Suzuki, A.; Harley, J.B.; Shirasawa, S.; Sawada, T.; Bae, S.C.; Tokuhiro, S.; Chang, X.; Sekine, A.; Takahashi, A.; Tsunoda, T.; Ohnishi, Y.; Kaufman, K.M.; Kang, C.P.; Kang, C.; Otsubo, S.; Yumura, W.; Mimori, A.; Koike, T.; Nakamura, Y.; Sasazuki, T.; Yamamoto, K. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet., 2005, 37, 478-485.
98. Simmonds, M.J.; Brand, O.J.; Barrett, J.C.; Newby, P.R.; Franklyn, J.A.; Gough, S.C. Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3. Clin. Endocrinol. (Oxf), 2010, 73, 654-660.
99. Newby, P.R.; Pickles, O.J.; Mazumdar, S.; Brand, O.J.; Carr-Smith, J.D.; Pearce, S.H.; Franklyn, J.A.; Evans, D.M.; Simmonds, M.J.; Gough, S.C. Follow-up of potential novel Graves' disease susceptibility loci, identified in the UK WTCCC genome-wide nonsynonymous SNP study. Eur. J. Hum. Genet., 2010, 18, 1021-1026.
100. Barrett, J.C.; Clayton, D.G.; Concannon, P.; Akolkar, B.; Cooper, J.D.; Erlich, H.A.; Julier, C.; Morahan, G.; Nerup, J.; Nierras, C.; Plagnol, V.; Pociot, F.; Schuilenburg, H.; Smyth, D.J.; Stevens, H.; Todd, J.A.; Walker, N.M.; Rich, S.S. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet., 2009, 41, 703-707.
101. Smyth, D.J.; Cooper, J.D.; Bailey, R.; Field, S.; Burren, O.; Smink, L.J.; Guja, C.; Ionescu-Tirgoviste, C.; Widmer, B.; Dunger, D.B.; Savage, D.A.; Walker, N.M.; Clayton, D.G.; Todd, J.A. A genomewide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet., 2006, 38, 617-619.
102. WTCCC Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 2007, 447, 661-678.
103. Todd, J.A.; Walker, N.M.; Cooper, J.D.; Smyth, D.J.; Downes, K.; Plagnol, V.; Bailey, R.; Nejentsev, S.; Field, S.F.; Payne, F.; Lowe, C.E.; Szeszko, J.S.; Hafler, J.P.; Zeitels, L.; Yang, J.H.; Vella, A.; Nutland, S.; Stevens, H.E.; Schuilenburg, H.; Coleman, G.; Maisuria, M.; Meadows, W.; Smink, L.J.; Healy, B.; Burren, O.S.; Lam, A.A.; Ovington, N.R.; Allen, J.; Adlem, E.; Leung, H.T.; Wallace, C.; Howson, J.M.; Guja, C.; Ionescu-Tirgoviste, C.; Simmonds, M.J.; Heward, J.M.; Gough, S.C.; Dunger, D.B.; Wicker, L.S.; Clayton, D.G. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet., 2007, 39, 857-864.
104. Hafler, J.P.; Maier, L.M.; Cooper, J.D.; Plagnol, V.; Hinks, A.; Simmonds, M.J.; Stevens, H.E.; Walker, N.M.; Healy, B.; Howson, J.M.; Maisuria, M.; Duley, S.; Coleman, G.; Gough, S.C.; Worthington, J.; Kuchroo, V.K.; Wicker, L.S.; Todd, J.A. CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun., 2009, 10, 5-10.
105. Alkan, C.; Coe, B.P.; Eichler, E.E. Genome structural variation discovery and genotyping. Nat. Rev. Genet., 2011, 12, 363-376.
106. Craddock, N.; Hurles, M.E.; Cardin, N.; Pearson, R.D.; Plagnol, V.; Robson, S.; Vukcevic, D.; Barnes, C.; Conrad, D.F.; Giannoulatou, E.; Holmes, C.; Marchini, J.L.; Stirrups, K.; Tobin, M.D.; Wain, L.V.; Yau, C.; Aerts, J.; Ahmad, T.; Andrews, T.D.; Arbury, H.; Attwood, A.; Auton, A.; Ball, S.G.; Balmforth, A.J.; Barrett, J.C.; Barroso, I.; Barton, A.; Bennett, A.J.; Bhaskar, S.; Blaszczyk, K.; Bowes, J.; Brand, O.J.; Braund, P.S.; Bredin, F.; Breen, G.; Brown, M.J.; Bruce, I.N.; Bull, J.; Burren, O.S.; Burton, J.; Byrnes, J.; Caesar, S.; Clee, C.M.; Coffey, A.J.; Connell, J.M.; Cooper, J.D.; Dominiczak, A.F.; Downes, K.; Drummond, H.E.; Dudakia, D.; Dunham, A.; Ebbs, B.; Eccles, D.; Edkins, S.; Edwards, C.; Elliot, A.; Emery, P.; Evans, D.M.; Evans, G.; Eyre, S.; Farmer, A.; Ferrier, I.N.; Feuk, L.; Fitzgerald, T.; Flynn, E.; Forbes, A.; Forty, L.; Franklyn, J.A.; Freathy, R.M.; Gibbs, P.; Gilbert, P.; Gokumen, O.; Gordon-Smith, K.; Gray, E.; Green, E.; Groves, C.J.; Grozeva, D.; Gwilliam, R.; Hall, A.; Hammond, N.; Hardy, M.; Harrison, P.; Hassanali, N.; Hebaishi, H.; Hines, S.; Hinks, A.; Hitman, G.A.; Hocking, L.; Howard, E.; Howard, P.; Howson, J.M.; Hughes, D.; Hunt, S.; Isaacs, J.D.; Jain, M.; Jewell, D.P.; Johnson, T.; Jolley, J.D.; Jones, I.R.; Jones, L.A.; Kirov, G.; Langford, C.F.; Lango-Allen, H.; Lathrop, G.M.; Lee, J.; Lee, K.L.; Lees, C.; Lewis, K.; Lindgren, C.M.; Maisuria-Armer, M.; Maller, J.; Mansfield, J.; Martin, P.; Massey, D.C.; McArdle, W.L.; McGuffin, P.; McLay, K.E.; Mentzer, A.; Mimmack, M.L.; Morgan, A.E.; Morris, A.P.; Mowat, C.; Myers, S.; Newman, W.; Nimmo, E.R.; O'Donovan, M.C.; Onipinla, A.; Onyiah, I.; Ovington, N.R.; Owen, M.J.; Palin, K.; Parnell, K.; Pernet, D.; Perry, J.R.; Phillips, A.; Pinto, D.; Prescott, N.J.; Prokopenko, I.; Quail, M.A.; Rafelt, S.; Rayner, N.W.; Redon, R.; Reid, D.M.; Renwick; Ring, S.M.; Robertson, N.; Russell, E.; St Clair, D.; Sambrook, J.G.; Sanderson, J.D.; Schuilenburg, H.; Scott, C.E.; Scott, R.; Seal, S.; Shaw-Hawkins, S.; Shields, B.M.; Simmonds, M.J.; Smyth, D.J.; Somaskantharajah, E.; Spanova, K.; Steer, S.; Stephens, J.; Stevens, H.E.; Stone, M.A.; Su, Z.; Symmons, D.P.; Thompson, J.R.; Thomson, W.; Travers, M.E.; Turnbull, C.; Valsesia, A.; Walker, M.; Walker, N.M.; Wallace, C.; Warren- Perry, M.; Watkins, N.A.; Webster, J.; Weedon, M.N.; Wilson, A.G.; Woodburn, M.; Wordsworth, B.P.; Young, A.H.; Zeggini, E.; Carter, N.P.; Frayling, T.M.; Lee, C.; McVean, G.; Munroe, P.B.; Palotie, A.; Sawcer, S.J.; Scherer, S.W.; Strachan, D.P.; Tyler- Smith, C.; Brown, M.A.; Burton, P.R.; Caulfield, M.J.; Compston, A.; Farrall, M.; Gough, S.C.; Hall, A.S.; Hattersley, A.T.; Hill, A.V.; Mathew, C.G.; Pembrey, M.; Satsangi, J.; Stratton, M.R.; Worthington, J.; Deloukas, P.; Duncanson, A.; Kwiatkowski, D.P.; McCarthy, M.I.; Ouwehand, W.; Parkes, M.; Rahman, N.; Todd, J.A.; Samani, N.J.; Donnelly, P. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature, 2010, 464, 713-720.
107. Brand, O.J.; Gough, S.C. Copy number variation in common disease. Thyroid, 2011, 21, 1-4.
108. Huber, A.K.; Concepcion, E.S.; Gandhi, A.; Menconi, F.; Smith, E.P.; Keddache, M.; Tomer, Y. Analysis of immune regulatory genes' copy number variants in Graves' disease. Thyroid, 2011, 21, 69-74.
109. Consortium, T.G.P. A map of human genome variation from population-scale sequencing. Nature, 2010, 467, 1061-1073.
110. Hawkins, R.D.; Hon, G.C.; Ren, B. Next-generation genomics: an integrative approach. Nat. Rev. Genet., 2010, 11, 476-486.
111. Inaba, H.; Martin, W.; De Groot, A.S.; Qin, S.; De Groot L.J. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease. J. Clin. Endocrinol. Metab., 2006, 91, 2286-2294.
112. Sawai, Y.; DeGroot, L.J. Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. J. Clin. Endocrinol. Metab., 2000, 85, 1176-1179.
113. Misrahi, M.; Loosfelt, H.; Atger, M.; Sar, S.; Guiochon-Mantel, A.; Milgrom, E. Cloning, sequencing and expression of human TSH receptor. Biochem. Biophys. Res. Commun., 1990, 166, 394-403.
114. Libert, F.; Lefort, A.; Gerard, C.; Parmentier, M.; Perret, J.; Ludgate, M.; Dumont, J.E.; Vassart, G. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem. Biophys. Res. Commun., 1989, 165, 1250-1255.
115. Kaczur, V.; Puskas, L.G.; Nagy, Z.U.; Miled, N.; Rebai, A.; Juhasz, F.; Kupihar, Z.; Zvara, A.; Hackler, L., Jr.; Farid, N.R. Cleavage of the human thyrotropin receptor by ADAM10 is regulated by thyrotropin. J. Mol. Recognit., 2007, 20, 392-404.
116. Sanders, J.; Chirgadze, D.Y.; Sanders, P.; Baker, S.; Sullivan, A.; Bhardwaja, A.; Bolton, J.; Reeve, M.; Nakatake, N.; Evans, M.; Richards, T.; Powell, M.; Miguel, R.N.; Blundell, T.L.; Furmaniak, J.; Smith, B.R. Crystal Structure of the TSH Receptor in Complex with a Thyroid-Stimulating Autoantibody. Thyroid, 2007, 17, 395-410.
117. Graves, P.N.; Tomer, Y.; Davies, T.F. Cloning and sequencing of a 1.3 KB variant of human thyrotropin receptor mRNA lacking the transmembrane domain. Biochem. Biophys. Res. Commun., 1992, 187, 1135-1143.
118. Takeshita, A.; Nagayama, Y.; Fujiyama, K.; Yokoyama, N.; Namba, H.; Yamashita, S.; Izumi, M.; Nagataki, S. Molecular cloning and sequencing of an alternatively spliced form of the human thyrotropin receptor transcript. Biochem. Biophys. Res. Commun., 1992, 188, 1214-1219.
119. Hunt, N.; Wiley, K.P.; Abend, N.; Balvers, M.; Jahner, D.; Northemann, W.; Ivell, R. Novel splicing variants of the human thyrotropin receptor encode truncated polypeptides without a membrane-spanning domain. Endocrine, 1995, 3, 233-240.
120. Vafiadis, P.; Bennett, S.T.; Todd, J.A.; Nadeau, J.; Grabs, R.; Goodyer, C.G.; Wickramasinghe, S.; Colle, E.; Polychronakos, C. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet., 1997, 15, 289-292.
121. Pugliese, A.; Zeller, M.; Fernandez, A., Jr.; Zalcberg, L.J.; Bartlett, R.J.; Ricordi, C.; Pietropaolo, M.; Eisenbarth, G.S.; Bennett, S.T.; Patel, D.D. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet., 1997, 15, 293-297.
122. Wegner, N.; Lundberg, K.; Kinloch, A.; Fisher, B.; Malmstrom, V.; Feldmann, M.; Venables, P.J. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev., 2010, 233, 34-54.
123. Waterhouse, P.; Penninger, J.M.; Timms, E.; Wakeham, A.; Shahinian, A.; Lee, K.P.; Thompson, C.B.; Griesser, H.; Mak, T.W. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science, 1995, 270, 985-988.
124. Tivol, E.A.; Borriello, F.; Schweitzer, A.N.; Lynch, W.P.; Bluestone, J.A.; Sharpe, A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity, 1995, 3, 541-547.
125. Eggena, M.P.; Walker, L.S.; Nagabhushanam, V.; Barron, L.; Chodos, A.; Abbas, A.K. Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen. J. Exp. Med., 2004, 199, 1725-1730.
126. Walker, L.S.; Ausubel, L.J.; Chodos, A.; Bekarian, N.; Abbas, A.K. CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen. J. Immunol., 2002, 169, 6202-6209.
127. Wing, K.; Onishi, Y.; Prieto-Martin, P.; Yamaguchi, T.; Miyara, M.; Fehervari, Z.; Nomura, T.; Sakaguchi, S. CTLA-4 control over Foxp3+ regulatory T cell function. Science, 2008, 322, 271-275.
128. Verhagen, J.; Gabrysova, L.; Minaee, S.; Sabatos, C.A.; Anderson, G.; Sharpe, A.H.; Wraith, D.C. Enhanced selection of FoxP3+ Tregulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease. Proc. Natl. Acad. Sci. U S A, 2009, 106, 3306-3311.
129. Qureshi, O.S.; Zheng, Y.; Nakamura, K.; Attridge, K.; Manzotti, C.; Schmidt, E.M.; Baker, J.; Jeffery, L.E.; Kaur, S.; Briggs, Z.; Hou, T.Z.; Futter, C.E.; Anderson, G.; Walker, L.S.; Sansom, D.M. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science, 2011, 332, 600-603.
130. Brand, O.; Gough, S.; Heward, J. HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert. Rev. Mol. Med., 2005, 7, 1-15.
131. Vang, T.; Congia, M.; Macis, M.D.; Musumeci, L.; Orru, V.; Zavattari, P.; Nika, K.; Tautz, L.; Tasken, K.; Cucca, F.; Mustelin, T.; Bottini, N. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet., 2005, 37, 1317-1319.
132. Rieck, M.; Arechiga, A.; Onengut-Gumuscu, S.; Greenbaum, C.; Concannon, P.; Buckner, J.H. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J. Immunol., 2007, 179, 4704-4710.
133. Vaughan, A.T.; Roghanian, A.; Cragg, M.S. B cells--masters of the immunoverse. Int. J. Biochem. Cell Biol., 2011, 43, 280-285.
134. Matsushita, T.; Horikawa, M.; Iwata, Y.; Tedder, T.F. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol., 2010, 185, 2240-2252.
135. Wongsurawat, T.; Nakkuntod, J.; Charoenwongse, P.; Snabboon, T.; Sridama, V.; Hirankarn, N. The association between HLA class II haplotype with Graves' disease in Thai population. Tissue Antigens, 2006, 67, 79-83.
136. Farid, N.R.; Barnard, J.M.; Marshall, W.H. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease. Tissue Antigens, 1976, 8, 181-189.
137. Grumet, F.C.; Payne, R.O.; Konishi, J.; Kriss, J.P. HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J. Clin. Endocrinol. Metab., 1974, 39, 1115-1119.
138. Mather, B.A.; Roberts, D.F.; Scanlon, M.F.; Mukhtar, E.D.; Davies, T.F.; Smith, B.R.; Hall, R. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives. Clin. Endocrinol. (Oxf), 1980, 12, 155-163.
139. Huang, S.M.; Wu, T.J.; Lee, T.D.; Yang, E.K.; Shaw, C.K.; Yeh, C.C. The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people. Tissue Antigens, 2003, 61, 154-158.
140. Vaidya, B.; Imrie, H.; Perros, P.; Young, E.T.; Kelly, W.F.; Carr, D.; Large, D.M.; Toft, A.D.; McCarthy, M.I.; Kendall-Taylor, P.; Pearce, S.H. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum. Mol. Genet., 1999, 8, 1195-1199.
141. Furugaki, K.; Shirasawa, S.; Ishikawa, N.; Ito, K.; Kubota, S.; Kuma, K.; Tamai, H.; Akamizu, T.; Hiratani, H.; Tanaka, M.; Sasazuki, T. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J. Hum. Genet., 2004, 49, 166-168.
142. Simmonds, M.J.; Heward, J.M.; Franklyn, J.A.; Gough, S.C. The CD40 Kozak SNP: a new susceptibility loci for Graves' disease? Clin. Endocrinol. (Oxf), 2005, 63, 232-233.
143. Jacobson, E.M.; Huber, A.K.; Akeno, N.; Sivak, M.; Li, C.W.; Concepcion, E.; Ho, K.; Tomer, Y. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun., 2007, 8, 205-214.
144. Simmonds, M.J.; Heward, J.M.; Carr-Smith, J.; Foxall, H.; Franklyn, J.A.; Gough, S.C. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J. Clin. Endocrinol. Metab., 2006, 91, 1056-1061.
145. Owen, C.J.; Kelly, H.; Eden, J.A.; Merriman, M.E.; Pearce, S.H.; Merriman, T.R. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J. Clin. Endocrinol. Metab., 2007, 92, 1106-1111.
146. Kotani, T.; Kato, E.; Hirai, K.; Kuma, K.; Ohtaki, S. Immunoglobulin G subclasses of anti-thyroid peroxidase autoantibodies in human autoimmune thyroid diseases. Endocrinol. Jpn., 1986, 33, 505-510.
147. Kotani, T.; Umeki, K.; Matsunaga, S.; Kato, E.; Ohtaki, S. Detection of autoantibodies to thyroid peroxidase in autoimmune thyroid diseases by micro-ELISA and immunoblotting. J. Clin. Endocrinol. Metab., 1986, 62, 928-933.
148. Ludgate, M.; Vassart, G. The molecular genetics of three thyroid autoantigens: thyroglobulin, thyroid peroxidase and the thyrotropin receptor. Autoimmunity, 1990, 7, 201-211.
149. Pirro, M.T.; De Filippis, V.; Di Cerbo, A.; Scillitani, A.; Liuzzi, A.; Tassi, V. Thyroperoxidase microsatellite polymorphism in thyroid diseases. Thyroid, 1995, 5, 461-464.
150. Sutherland, A.; Davies, J.; Owen, C.J.; Vaikkakara, S.; Walker, C.; Cheetham, T.D.; James, R.A.; Perros, P.; Donaldson, P.T.; Cordell, H.J.; Quinton, R.; Pearce, S.H. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J. Clin. Endocrinol. Metab., 2007, 92, 3338-3341.
151. Chistiakov, D.A.; Savost'anov, K.V.; Turakulov, R.I. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study. Mol. Genet. Metab., 2004, 83, 264-270.
152. Yesmin, K.; Hargreaves, C.; Newby, P.R.; Brand, O.J.; Heward, J.M.; Franklyn, J.A.; Gough, S.C.; Simmonds, M.J. Association of FcGRIIa with Graves' disease: a potential role for dysregulated autoantibody clearance in disease onset/progression. Clin. Endocrinol. (Oxf), 2010, 73, 119-125.
153. Huber, A.K.; Jacobson, E.M.; Jazdzewski, K.; Concepcion, E.S.; Tomer, Y. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J. Clin. Endocrinol. Metab., 2008, 93, 1077-1081.
154. Vives-Pi, M.; Vargas, F.; James, R.F.; Trowsdale, J.; Costa, M.; Sospedra, M.; Somoza, N.; Obiols, G.; Tampe, R.; Pujol-Borrell, R. Proteasome subunits, low-molecular-mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin-dependent diabetes mellitus: implications for autoimmunity. Tissue Antigens, 1997, 50, 153-163.
155. Heward, J.M.; Allahabadia, A.; Sheppard, M.C.; Barnett, A.H.; Franklyn, J.A.; Gough, S.C. Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB 10304-DQB1 02-DQA1 0501. Clin. Endocrinol. (Oxf), 1999, 51, 115-118.
156. Newby, P.R.; Roberts-Davies, E.L.; Brand, O.J.; Heward, J.M.; Franklyn, J.A.; Gough, S.C.; Simmonds, M.J. Tag SNP screening of the PDCD1 gene for association with Graves' disease. Clin. Endocrinol. (Oxf), 2007, 67, 125-128.
157. Simmonds, M.J.; Heward, J.M.; Howson, J.M.; Foxall, H.; Nithiyananthan, R.; Franklyn, J.A.; Gough, S.C. A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease. Genes Immun., 2004, 5, 267-273.
158. Nakkuntod, J.; Wongsurawat, T.; Charoenwongse, P.; Snabboon, T.; Sridama, V.; Hirankarn, N. Association of TNF-alpha, TNFbeta, IFN-gamma and IL-1Ra gene polymorphisms with Graves' disease in the Thai population. Asian Pac. J. Allergy Immunol., 2006, 24, 207-211.
159. Demaine, A.G.; Ratanachaiyavong, S.; Pope, R.; Ewins, D.; Millward, B.A.; McGregor, A.M. Thyroglobulin antibodies in Graves' disease are associated with T-cell receptor beta chain and major histocompatibility complex loci. Clin. Exp. Immunol., 1989, 77, 21-24.
160. Pickerill, A.P.; Watson, P.F.; Tandon, N.; Weetman, A.P. T cell receptor beta chain gene polymorphisms in Graves' disease. Acta Endocrinol. (Copenh), 1993, 128, 499-502.
161. Zhang, J.; Hu, S.; Wang, H. Expression of T cell receptor V(alpha) gene families in intrathyroidal T cells of Chinese patients with Graves' disease. Chin. Med. Sci. J., 2000, 15, 175-178.
162. Hiromatsu, Y.; Fukutani, T.; Ichimura, M.; Mukai, T.; Kaku, H.; Nakayama, H.; Miyake, I.; Shoji, S.; Koda, Y.; Bednarczuk, T. Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease. J. Clin. Endocrinol. Metab., 2005, 90, 296-301.
163. Heward, J.M.; Nithiyananthan, R.; Allahabadia, A.; Gibson, S.; Franklyn, J.A.; Gough, S.C. No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom. J. Clin. Endocrinol. Metab., 2001, 86, 3861-3863.
164. Blakemore, A.I.; Watson, P.F.; Weetman, A.P.; Duff, G.W. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J. Clin. Endocrinol. Metab., 1995, 80, 111-115.
165. Muhlberg, T.; Kirchberger, M.; Spitzweg, C.; Herrmann, F.; Heberling, H.J.; Heufelder, A.E. Lack of association of Graves' disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population. Eur. J. Endocrinol., 1998, 138, 686-690.
166. Ban, Y.; Taniyama, M.; Katagiri, T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid, 2000, 10, 475-480.
167. Ban, Y.; Taniyama, M. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J. Clin. Endocrinol. Metab., 2000, 85, 4639-4643.
168. Shirasawa, B.; Hanada, S.; Harada, M.; Tomozawa, N.; Hamano, K. Lobectomy for lung cancer in an elderly man on maintenance hemodialysis. Kyobu Geka, 2004, 57, 1094-1098.
169. Simmonds, M.J.; Yesmin, K.; Newby, P.R.; Brand, O.J.; Franklyn, J.A.; Gough, S.C.; Confirmation of association of chromosome 5q31-33 with United Kingdom Caucasian Graves' disease. Thyroid, 2010, 20, 413-417.